心力衰竭中的调控RNA
心力衰竭是心血管疾病的主要表现形式,已达到流行程度,其发生源于心脏稳态丧失,而稳态依赖基因表达的严密调控。该综述重新界定调控RNA(regRNA)概念,将编码蛋白质的信使RNA与微小RNA、长链非编码RNA、环状RNA一并纳入,讨论其在心力衰竭中的调控与功能作用,并探讨其用于诊断、预后判断和治疗的潜力,提出未来研究方向。
要点
- 综述提出regRNA概念,同时涵盖编码蛋白质的mRNA与各类非编码RNA。
- 系统讨论mRNA、微小RNA、长链非编码RNA和环状RNA在心力衰竭中的调控与功能。
- 探讨regRNA用于心力衰竭诊断、预后判断与治疗的价值并给出未来研究方向。
核心结论
- 调控RNA(regRNA)可同时包括编码蛋白质的RNA与非编码RNA,只要其直接或间接参与基因表达调控。
- mRNA、微小RNA、长链非编码RNA与环状RNA在心力衰竭中具有调控作用和功能角色,并可能用于诊断、预后判断和治疗。
研究设计与样本
- 综述类文章,围绕心力衰竭中调控RNA的调控机制与功能作用进行梳理与讨论。
主要发现
- 心力衰竭源于心脏稳态丧失,而稳态依赖基因表达的严密调控,该调控受多类RNA分子控制。
- 部分RNA编码蛋白质(信使RNA),另一部分无蛋白质编码能力,称为非编码RNA。
- 作者将regRNA概念扩展至同时涵盖编码蛋白质RNA与非编码RNA。
临床怎么用
- 综述提出regRNA概念,提示在心力衰竭中可将编码与非编码调控RNA共同纳入机制研究与诊疗转化探索。
- 作者讨论将regRNA用于心力衰竭诊断、预后判断和治疗的效用,并给出未来工作方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular disease is an enormous socioeconomic burden worldwide and remains a leading cause of mortality and disability despite significant efforts to improve treatments and personalize healthcare. Heart failure is the main manifestation of cardiovascular disease and has reached epidemic proportions. Heart failure follows a loss of cardiac homeostasis, which relies on a tight regulation of gene expression. This regulation is under the control of multiple types of RNA molecules, some encoding proteins (the so-called messenger RNAs) and others lacking protein-coding potential, named noncoding RNAs. In this review article, we aim to revisit the notion of regulatory RNA, which has been thus far mainly confined to noncoding RNA. Regulatory RNA, which we propose to abbreviate as regRNA, can include both protein-coding RNAs and noncoding RNAs, as long as they contribute, directly or indirectly, to the regulation of gene expression. We will address the regulation and functional role of messenger RNAs, microRNAs, long noncoding RNAs, and circular RNAs (ie, regRNAs) in heart failure. We will debate the utility of regRNAs to diagnose, prognosticate, and treat heart failure, and we will provide directions for future work.
引用
- Gomes CPC, Schroen B, Kuster GM, et al. Regulatory RNAs in Heart Failure. Circulation. 2020. PMID: 31986093. doi:10.1161/CIRCULATIONAHA.119.042474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。